Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
2m agoROHM Launches an Ultra-Compact Wireless Power Chipset for Wearables
26m agoCognizant's Innovation Network a Fast Track to Enterprise Value
26m agoLi Bang International Announces Regaining Compliance with Nasdaq Minimum Bid Price Requirement
27m agoMore Than a Discount: Drivers Who Bundle Home and Auto See Fewer Coverage Gaps and Smoother Claims
27m agoAmerican Water's Suzanne Chiavari Named 2026 AWWA George Warren Fuller Award Recipient
Ac Immune Ltd logo

Ac Immune Ltd

About

Ac Immune Ltd (NASDAQ:ACIU) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 7 2026
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly
Mar 19 2026
AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026
Mar 13 2026
AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update
Mar 5 2026
AC Immune Announces Upcoming Industry Symposium on Parkinson’s Disease and Presentation at AD/PD™ 2026
Feb 24 2026
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor

Financials

Revenue
$3.57 M
Market Cap
$280.9 M
EPS
-0.88

Community Chat

Ask AI

6ix6ixAIEvents